Nanobiotix Files Routine 6-K Report
Ticker: NBTX · Form: 6-K · Filed: May 28, 2025 · CIK: 1760854
Sentiment: neutral
Topics: sec-filing, routine-report, foreign-private-issuer
TL;DR
Nanobiotix filed a 6-K, just routine updates, nothing major to see here.
AI Summary
Nanobiotix S.A. filed a Form 6-K on May 28, 2025, to report its activities for the month of May 2025. The company, based in Paris, France, is a foreign private issuer and files its annual reports under Form 20-F. This filing does not appear to contain specific financial updates or material events beyond its routine reporting status.
Why It Matters
This filing indicates Nanobiotix is fulfilling its regular reporting obligations as a foreign private issuer with the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material financial information or strategic changes.
Key Numbers
- 001-39777 — SEC File Number (Identifies the company's registration with the SEC.)
Key Players & Entities
- Nanobiotix S.A. (company) — Registrant
- 001-39777 (dollar_amount) — SEC File Number
- 20250528 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that is made public in their home country, filed with a stock exchange, or distributed to their security holders.
What period does this Form 6-K cover?
This Form 6-K is for the month of May 2025.
Is Nanobiotix S.A. a U.S. or foreign company?
Nanobiotix S.A. is a foreign private issuer, as indicated by its filing of Form 6-K and the checkmark next to Form 20-F.
Where is Nanobiotix S.A. headquartered?
Nanobiotix S.A. is headquartered at 60 Rue de Wattignies, 75012 Paris, France.
Does this filing contain specific financial results for May 2025?
This filing is a routine report and does not appear to contain specific financial results or material event disclosures for May 2025; it primarily serves to fulfill reporting obligations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 28, 2025 regarding Nanobiotix S.A. (NBTX).